CLSI SIDP 2026 Webinar
From Update to Uptake: Implementing the CLSI M100 Standards to Advance Antimicrobial Stewardship and Clinical Practice
This annual continuing education webinar collaboration between CLSI, the Society of Infectious Diseases Pharmacists (SIDP), and the American College of Clinical Pharmacy Practice and Infectious Diseases Research Networks (ACCP ID PRN) delivers the latest updates to CLSI M100 36 ed. Standards for Antimicrobial Susceptibility Testing and explores practical approaches for integrating these changes into clinical workflows. Faculty will highlight the critical partnership between pharmacists and laboratory professionals to support effective implementation and optimize patient care outcomes. Interactive audience polling will be incorporated throughout the session, followed by a live Q&A discussion.
This webinar is free for CLSI, SIDP, and ACCP ID PRN members. CLSI members login with your account. SIDP and ACCP ID PRN members register on SIDP’s website.
This activity was planned to meet the educational needs of Pharmacists and Laboratory Professionals.
Date: 30 April 2026 | 1-2:30pm EDT
{{FormatPrice(currentPrice)}}
Free
{{FormatPrice(nonMemberPrice)}} List PriceLearning Objectives:
- Describe updates in the recent standards related to breakpoints and susceptibility testing for aztreonam-avibactam for Enterobacterales, trimethoprim-sulfamethoxazole susceptibility testing for b-hemolytic Streptococcus species, and antibiogram use for empiric treatment of infections due to anaerobic organisms
- Discuss strategies to integrate new breakpoints, susceptibility testing considerations, and anaerobic antibiogram data into laboratory and patient care workflows to support clinical decision-making
- Identify opportunities for laboratory and clinical teams to collaborate on implementation of standards updates to enhance infectious diseases practices and improve patient care
Intermediate: Refresher course. Some basic knowledge required, for the experienced staff technologist with some years of experience.
CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E® Program.
Learning Objectives:
- Describe updates in the recent standards related to breakpoints and susceptibility testing for aztreonam-avibactam for Enterobacterales, trimethoprim-sulfamethoxazole susceptibility testing for b-hemolytic Streptococcus species, and antibiogram use for empiric treatment of infections due to anaerobic organisms
- Discuss strategies to integrate new breakpoints, susceptibility testing considerations, and anaerobic antibiogram data into laboratory and patient care workflows to support clinical decision-making
- Identify opportunities for laboratory and clinical teams to collaborate on implementation of standards updates to enhance infectious diseases practices and improve patient care
Intermediate: Refresher course. Some basic knowledge required, for the experienced staff technologist with some years of experience.
CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E® Program.